This project was completed by Intensity. Intensity joined Secretariat on February 1, 2023.
A consumer healthcare products company was alleged to have misrepresented certain medical and health benefits of over-the-counter multivitamin products, causing alleged overpayment of those products by consumers. Plaintiffs in the case sought to certify a class of affected consumers and initiate class action recovery of class-wide economic damages.
Intensity was retained to determine an appropriate methodology for evaluating class certification, and to perform economic analysis related to alleged price premiums on products that were advertised with certain false claims. Intensity analyzed methodologies for determining damages and examined a proposed methodology based on product sales data and consumer demographics. As part of our work, we evaluated the reliability of available data related to prices paid by consumers. In addition, Intensity performed an analysis of damages to the class resulting from the alleged misconduct and estimated those damages using product sales, pricing, and profitability.
Economic issues included class certification, price premiums, common class-wide impact, unfair competition, and false advertising.
Statistics Tools Chart A Path For AI Use In Expert Testimony
As AI and machine learning tools become more common in expert workflows, courts are increasingly scrutinizing their use under Federal Rule of Evidence 702. In The Risks and a Path Forward for AI and Machine Learning Tools in Expert Testimony, we examine recent cases where AI-assisted opinions were excluded due to concerns about reliability, transparency, and expert understanding.
In this GIR article, Stephen Millington and Dominique Dondelinger examine the growing fraud risks facing the Gulf region amid rapid economic expansion and transformative Vision 2030 strategies.
Public Cos. Must Heed Disclosure Risks Amid Trade Chaos
Ongoing uncertainties caused by the trade war and President Donald Trump’s evolving stance on tariffs and trade restrictions, including sanctions and export controls, have exponentially escalated financial reporting pressures on public companies. In this article, we discuss the key financial reporting and disclosure risks, as well as takeaways, for public companies as they navigate significant market instability in international trade.